| Bilgi: |
COVID-19 vaccine for younger kids a step closer
COVID-19 vaccination for children under 12 is one step closer to reality. Pfizer announced that it submitted data of their phase 2 and phase 3 trial of their COVID-19 in children ages 5–11 to the Food and Drug Administration (FDA). A formal submission to request emergency use authorization (EUA) of the company's COVID-19 vaccine in children in this age group is expected in the coming weeks. The FDA will need to analyze data before a decision…
https://newsnetwork.mayoclinic.org/?p=319693
|
